Tradestie Institutional Equity Comparison Engine

ATYR vs NVCT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATYR Overall Edge

ATYR Captures Institutional Edge (2โ€“1 Pillars ยท 1โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to aTyr Pharma, Inc. Common Stock (ATYR) driven by superior Momentum & Technical, Options & Structure while NVCT counters with relative strength in Growth & Margin. Fundamentally, ATYR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus NVCT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ATYR sits in UNCLASSIFIED (36th %ile IV; Dealer Gamma Walls on Pro) against NVCT sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ATYR N/M vs NVCT N/M Fwd P/E
Growth & Margin Winner NVCT
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner ATYR
1Y +558.7% vs +218.6% ยท 52W Pos 62% vs 57%
Options & Structure Winner ATYR
UNCLASSIFIED (36th %ile IV) vs BREAKDOWN (9th %ile IV)
ATYR NASDAQ
aTyr Pharma, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$4.96
-5.34% 1D
Market Cap $15.6M
1M Return +2788.76%
1Y Return +558.7%
Forward P/E N/M
Unified AI Score
34.3 / 100 SELL
Tech 50.0 Fund 36.0 Flow 69.0 Mom 50.0
NVCT NASDAQ
Nuvectis Pharma, Inc. Common Stock
Pharmaceutical Preparations
$19.18
+0.37% 1D
Market Cap $696.0M
1M Return +1.27%
1Y Return +218.6%
Forward P/E N/M
Unified AI Score
53.4 / 100 HOLD
Tech 58.0 Fund 59.0 Flow 66.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ATYR +558.7% NVCT +218.6% Spread: +340.1 pp (ATYR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ATYR TTM Op. Margin: 0.0% NVCT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ATYR vs NVCT. Trailing 12-month operating profitability (ATYR 0.0% vs NVCT 0.0%) and valuation multiples (ATYR N/M vs NVCT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ATYR (1) vs NVCT (4)
Institutional Metric ATYR NVCT Criterion Row Winner
Market Capitalization Scale $15.6M $696.0M Larger Scale NVCT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -93.7% -67.0% Higher ROE NVCT
52-Week Range Position Momentum 62% ($0โ€“$8) 57% ($6โ€“$29) Stronger Trend ATYR
Beta / 30D Volatility Risk Regime -9.67ฮฒ ยท 13806% Vol 0.70ฮฒ ยท 82% Vol Lower Realized Risk NVCT
Unified Institutional Score Composite Signal 34.3 / 100 (SELL) 53.4 / 100 (HOLD) Higher Composite NVCT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ATYR vs NVCT Buy Guide
ATYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 36th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ATYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NVCT BREAKDOWN
99d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live NVCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ATYR nor NVCT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.